News

Italy Drug & Device Rules for 2026 Trials

3 min

QA/QC for Pharmaceutical Analysis in 2026

2 min

Ascentage Pharma’s 17 Advances at EHA 2026

EMA · 2 min

Oncology Congress Insights for Pharma Teams

oncology · 2 min

FDA Delays Camizestrant Breast Cancer Review

FDA · breast cancer · 2 min

Bio/Pharma Outlook 2026: Regulatory Updates and Implications

3 min

Innovent Biologics Shares Surge 10% Following Pfizer Deal

2 min

Arrowhead Pharmaceuticals Unveils Positive Clinical Data at EAS Congress

cardiometabolic disorders · 2 min

Innovent Biologics and Pfizer's $10.5 Billion Cancer Drug Deal

cancer · 2 min

LENZ Therapeutics Submits VIZZ® Application to EMA for Presbyopia

European Medicines Agency · Presbyopia · 2 min

Critical Medicines Act: Council and Parliament Reach Provisional Deal

2 min

Imfinzi Receives FDA Approval for Bladder Cancer Treatment

FDA · oncology · 2 min